Neumora Therapeutics Announces $112 Million Series B Financing
Read More
Archive for Press Releases
Neumora Expands Precision Neuroscience Pipeline with Novel M4 Receptor Modulator Program Through Exclusive License Agreement with Vanderbilt University
Read More
Neumora Therapeutics Launches to Pioneer a New Era of Precision Medicines for Brain Diseases
Read More
Amgen and Neumora Therapeutics Announce Strategic R&D Collaboration to Accelerate Novel Precision Therapies for Brain Diseases
Read More